Tamoxifen Market: We’re Entering an Era!
Tamoxifen
is a type of selective estrogen receptor modulator (SERM) indicated
for the treatment of women with high risk of breast cancer. Since its
approval in 1998, tamoxifen has been used to treat millions of
patients diagnosed with hormone receptor positive, early stage of
breast cancer after surgery to reduce the risk of recurrence. It is
the first choice for treatment of premenopausal women. Tamoxifen is
the generic name for Nolvadex. Tamoxifen has off-label usage for the
treatment of infertility, gynecomastia, retroperitoneal fibrosis, and
idiopathic sclerosing mesenteritis.
Tamoxifen is a type of selective estrogen receptor
modulator. The main pharmacologic action of Tamoxifen is to block the
growth-promoting effects of estrogens on breast cancer.
In bone cells, selective estrogen modulators interact with receptors
the way estrogen does and strengthens bones. Tamoxifen is
available in various forms such as powder, capsules, oral solution,
and tablets
Tamoxifen Market – Regional Insights
On the basis of region, the
global tamoxifen market is segmented into North America, Europe,
Latin America, Asia Pacific, Middle East, and Africa. North America
tamoxifen market holds the dominant position, owing to high
acceptance and high price of the drug in treating breast cancer. For
instance, according to GoodRx Inc. 2018 pricing detail, 30 tablets of
tamoxifen 20mg cost around US$ 65.71 on an average. Moreover,
increasing prevalence of breast cancer has propelled the tamoxifen
market growth in the North America region. According to 2018, U.S.
Breast Cancer Organization statistics, around 1 in 8 U.S. women are
estimated to develop invasive breast cancer during the course of her
life. Moreover, around 266,120 women are expected to be diagnosed
with invasive breast cancer in the U.S. in 2018.
Asia Pacific is expected to
witness significant growth in the market over the forecast period,
owing to its increasing number of people vulnerable to various
chronic diseases and increasing healthcare initiatives. For instance,
according to published article in the Lancet Oncology 2014, breast
cancer is expected to rise from less than 60 cases per 100,000 woman
aged 55-69 years to over 100 cases per 100,000 woman by 2021,
reaching 2.5 million cases overall by 2021.
Tamoxifen Market – Competitive
Landscape
Key players operating in the global tamoxifen
market include Teva Pharmaceutical Industries
Ltd, AstraZeneca plc, Aegis
pharmaceuticals, Watson laboratories, Inc., Allergan plc, Mylan
N.V., and Apotex Inc.
Inquire Here Before Purchase
of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1801
Tamoxifen Market Taxonomy
On the basis of dosage form, the global
tamoxifen market is segmented into:
-
Powder
-
Capsule
-
Oral Solution
-
Tablet
On the basis of indication, the global
tamoxifen market is segmented into:
-
Breast Cancer
-
Others
Tamoxifen Market,Tamoxifen trends,Tamoxifen growth,Tamoxifen insights,Tamoxifen outlook
On the basis of region, the global tamoxifen market is segmented into:
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments
Post a Comment